ADVANCE 2020 grant program: applications open

Pfizer Inc. and Eli Lilly and Company are pleased to announce the call for proposals for the 3rd Global Awards for Advancing Chronic Pain Research (ADVANCE), an independently-reviewed, competitive grants program. The Global Awards for Advancing Chronic Pain Research...
EFIC COVID-19 Task Force

EFIC COVID-19 Task Force

The EFIC COVID-19 Task Force was created after realizing the need for news related to COVID-19 being distributed and shared with our community which is looking for advice with regards to pain treatment of their patients. The intended outcome is to distribute relevant...
Apply for the EFIC-Grünenthal Grant (E-G-G) 2021!

Apply for the EFIC-Grünenthal Grant (E-G-G) 2021!

The EFIC-Grünenthal-Grant (E-G-G) is now accepting applications. Early-career scientists from across Europe can submit their innovative research projects in the area of chronic pain to be considered for a research grant from this prestigious scheme. How does it work?...
EFIC-Grünenthal-Grant (E-G-G) Relaunching in 2020

EFIC-Grünenthal-Grant (E-G-G) Relaunching in 2020

In February 2020, the EFIC-Grünenthal Grant (E-G-G) will reopen applications for its pain research grant worth a total of €200,000. E-G-G is a research grant scheme awarded by the European Pain Federation EFIC and sponsored by the pharmaceutical company Grünenthal...